QuantumSi Inc (QSI) Company Report Dec. 23, 2022, 00:25 UTC 47 New Form 3 for Quantum-Si Incorporated Comment Full text
QuantumSi Inc (QSI) Company Report Dec. 23, 2022, 00:10 UTC 44 Quantum-Si to Participate in the 41st Annual J.P. Morgan Healthcare Conference Comment Full text
Neurocrine Biosciences Inc (NBIX) Company Report Dec. 23, 2022, 00:05 UTC 43 Neurocrine Biosciences Announces U.S. FDA Accepts Supplemental New Drug Application for Valbenazine as a Treatment for Chorea Associated with Huntington Disease Comment Full text
Luna Innovations Incorporated (LUNA) Company Report Dec. 21, 2022, 16:40 UTC 49 Luna Wins Major Contract for Levee Monitoring Comment Full text
Moleculin Biotech Inc. (MBRX) Company Report Dec. 21, 2022, 16:35 UTC 45 Moleculin Biotech, Inc. SEC filing Comment Full text
NeuBase Therapeutics Inc. (NBSE) Company Report Dec. 21, 2022, 16:26 UTC 45 New SEC Form for NeuBase Therapeutics, Inc. Comment Full text
QuantumSi Inc (QSI) Company Report Dec. 21, 2022, 16:26 UTC 44 New Form 8-K for Quantum-Si Incorporated Comment Full text
Journey Medical Corporation (DERM) Company Report Dec. 21, 2022, 16:25 UTC 43 Journey Medical Corporation Announces Positive Comparative Pharmacokinetic (PK) Data for DFD-29 Comment Full text
QuantumSi Inc (QSI) Company Report Dec. 21, 2022, 16:25 UTC 43 Quantum-Si Announces Commercial Availability of PlatinumTM, theWorld’s First Next-Generation Single-Molecule Protein Sequencing Platform Comment Full text
QuantumSi Inc (QSI) Company Report Dec. 17, 2022, 14:58 UTC 46 New Form 4 for Quantum-Si Incorporated Comment Full text